Opportunity brief · SAM.gov special notice
TECHNOLOGY LICENSING OPPORTUNITY: SignalGen
Energy, Department of · Energy, Department of · TRIAD - DOE CONTRACTOR · Solicitation S-195368 · NAICS 541714 Research and Development in Biotechnology (Except Nanobiotechnology) · responses due 2027-03-22 · Open on SAM.gov ↗
- Posted
- 2026-09-22
- Place of work
- New Mexico
- Product or service code
- AN12 · Health R&D Services; Health Care Services; Applied Research
Putting the brief together: the incumbent, who else wins this work, the contracting office and past prices…
From the notice
A platform that predicts the right signal peptide for a specific protein Many medicines, vaccines, and biotechnology products rely on proteins reaching the right cellular compartment or secretion outside a cell. Whether a protein gets there in enough quantities depends on its signal peptide or leader sequence. Scientists can identify many existing signal peptides, but predicting which one will work best for a specific protein remains difficult. SignalGen uses generative AI to predict the signal peptide most likely to guide a protein to the right location. To make that prediction, it considers the protein, where it needs to go, and the organism it comes from. This approach gives researchers a new way to improve protein expression for medicines, vaccines, and biotechnology products. Overview: Proteins carry out many of the body's essential functions, but they can only do their job if they reach the right place inside or outside a cell. Many proteins rely on signal peptides to get there. Typically, a signal peptide is a short sequence segment at the beginning of a protein that acts like a built-in address label, helping direct the protein to the location where it is needed. Predicting the right signal peptide for a specific protein remains challenging. Existing software can identify known signal peptides or determine whether a protein already contains one, but it cannot predict which signal peptide is best suited to produce the desired protein expression and cellular location.
More open Research and Development in Biotechnology (Except Nanobiotechnology) contract opportunities
- TIDAL: Target-Induced Droplet Assembly of Ligands · Energy, Department of · NM · due 2026-12-08
- TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter · Energy, Department of · NM · due 2026-12-15
- TECHNOLOGY LICENSING OPPORTUNITY: NanoFET · Energy, Department of · NM · due 2026-12-17
- TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation · Energy, Department of · NM · due 2026-12-22
- Protein ENGineering (PENG) · Dept of Defense · due 2026-10-19
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories · Health and Human Services, Department of · due 2026-10-20
- Biobanking, Laboratory Analytics, and Associated Informatics Services for NIH Biorepositories · Health and Human Services, Department of · Small Business Set Aside - Total · due 2026-10-20
- Q--Amplicon Sequencing Services · Interior, Department of the · due 2026-10-23
All 27 open notices in NAICS 541714 · Research and Development in Biotechnology (Except Nanobiotechnology): who buys it and who wins it · Contracts in this industry coming up for re-bid · The contracting office · Energy, Department of: spending and contractors · Federal contracts in New Mexico